David Kwiatkowski, a traveling hospital technician who was sentenced to 39 years in prison for infecting patients in multiple states with hepatitis C through tainted syringes, has asked a federal judge to vacate his sentence, saying his lawyer was ineffective in representing him.
While HIV transmission has been significantly reduced over the past decades — especially among people who inject drugs— the recent national surge in opioid misuse threatens to reverse some of these gains. It is critical that that we utilize lessons learned from HIV to address this epidemic.
Prisons and jails can contribute to global epidemics of HIV, viral hepatitis and tuberculosis, and prison inmates and jail detainees have higher rates of those diseases, according to research released Sunday by the Johns Hopkins Bloomberg School of Public Health.
Twenty years ago, people specializing in hepatitis C never used the word "cure," and instead used the jargon "sustained virological response" (or SVR) only because we were not sure whether we were curing or suppressing the virus just as in HIV or hepatitis B. Today, almost like a miracle, the treatment of hepatitis C has changed, however. With one single daily pill for 8 or 12 weeks most people with hepatitis C will be cured. Despite these advances, successful management of hepatitis C remains a
When a new generation of hepatitis C drugs began coming on the market about a year and a half ago, some feared the millions who could be cured of the potentially deadly disease would never get them. The price for a three-month daily course began at $1,000 a pill.